Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/12/22 19:25 | 1/10/22 | IKNA | Health | BioPrd | Biological Products, (No Diag | Zhang Xiaoyan Michelle | MA | O | Chief Sc | S.dm | -12 | 12.00 | 0 | -1 | -2 | 44 | D | ||||||||||||||
12/14/21 20:48 | 12/10/21 | IKNA | Health | BioPrd | Biological Products, (No Diag | Zhang Xiaoyan Michelle | MA | O | Chief Sc | S.d | -15 | 14.76 | 0 | -1 | -2 | 44 | D | ||||||||||||||
12/14/21 20:29 | 12/10/21 | IKNA | Health | BioPrd | Biological Products, (No Diag | Formela Jean Francois | MA | D | S.m | -386 | 14.67 | 0 | -26 | -1 | 4,144 | I | |||||||||||||||
12/14/21 20:27 | 12/10/21 | IKNA | Health | BioPrd | Biological Products, (No Diag | Atlas Venture Fund Xi, L.P. | MA | T | S.m | -386 | 14.67 | 0 | -26 | -1 | 2,117 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |